Complement and its role in innate and adaptive immune responses
Tóm tắt
Từ khóa
Tài liệu tham khảo
Janeway CA Jr, Travers P, Walport M, Shlomchik M . Immunobiology: The Immune System in Health and Disease. 6th Edition. New York: Garland Publishing, 2005.
Volanakis JE, Frank MM . The Human Complement System in Health and Disease. New York: Marcel Dekker Inc., 1998.
Jensen JA, Festa E, Smith DS, Cayer M . The complement system of the nurse shark: hemolytic and comparative characteristics. Science 1981; 214:566–569.
Suzuki MM, Satoh N, Nonaka M . C6-like and C3-like molecules from the cephalochordate, amphioxus, suggest a cytolytic complement system in invertebrates. J Mol Evol 2002; 54:671–679.
Azumi K, De Santis R, De Tomaso A, et al. Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: “waiting for Godot”. Immunogenetics 2003; 55:570–581.
Al-Sharif WZ, Sunyer JO, Lambris JD, Smith LC . Sea urchin coelomocytes specifically express a homologue of the complement component C3. J Immunol 1998; 160:2983–2997.
Zhu Y, Thangamani S, Ho B, Ding JL . The ancient origin of the complement system. EMBO J 2005; 24:382–394.
Miller DJ, Hemmrich G, Ball EE, et al. The innate immune repertoire in cnidaria–ancestral complexity and stochastic gene loss. Genome Biol 2007; 8:R59.
Du Pasquier L, Litman GW . Origin and Evolution of the Vertebrate Immune System. Berlin: Springer Edition, 2000.
Medzhitov R, Janeway CA Jr . Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296:298–300.
Gordon S . Pattern recognition receptors: doubling up for the innate immune response. Cell 2002; 111:927–930.
Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RA . The collectins in innate immunity. Curr Opin Immunol 1996; 8:29–35.
Fujita T, Endo Y, Nonaka M . Primitive complement system–recognition and activation. Mol Immunol 2004; 41:103–111.
Harmat V, Gal P, Kardos J, et al. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions. J Mol Biol 2004; 342:1533–1546.
Bally I, Rossi V, Lunardi T, et al. Identification of the C1q-binding sites of human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J Biol Chem 2009; 284:19340–19348.
Gal P, Barna L, Kocsis A, Zavodszky P . Serine proteases of the classical and lectin pathways: similarities and differences. Immunobiology 2007; 212:267–277.
Matsushita M, Endo Y, Fujita T . MASP1 (MBL-associated serine protease 1). Immunobiology 1998; 199:340–347.
Dahl MR, Thiel S, Matsushita M, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001; 15:127–135.
Takahashi M, Iwaki D, Kanno K, et al. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol 2008; 180:6132–6138.
Dobo J, Harmat V, Beinrohr L, et al. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 2009; 183:1207–1214.
Hourcade DE . Properdin and complement activation: a fresh perspective. Curr Drug Targets 2008; 9:158–164.
Paques EP, Scholze H, Huber R . Purification and crystallization of human anaphylatoxin, C3a. Hoppe Seylers Z Physiol Chem 1980; 361:977–980.
Nagar B, Jones RG, Diefenbach RJ, Isenman DE, Rini JM . X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 1998; 280:1277–1281.
Janssen BJ, Huizinga EG, Raaijmakers HC, et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 2005; 437:505–511.
Milder FJ, Gomes L, Schouten A, et al. Factor B structure provides insights into activation of the central protease of the complement system. Nat Struct Mol Biol 2007; 14:224–228.
Torreira E, Tortajada A, Montes T, Rodriguez de Cordoba S, Llorca O . 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase. Proc Natl Acad Sci USA 2009; 106:882–887.
Krishnan V, Xu Y, Macon K, Volanakis JE, Narayana SV . The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. J Mol Biol 2007; 367:224–233.
Hourcade DE . The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 2006; 281:2128–2132.
Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE . Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 2007; 179:2600–2608.
Kimura Y, Miwa T, Zhou L, Song WC . Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 2008; 111:732–740.
Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12:682–687.
Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD . Complement and coagulation: strangers or partners in crime? Trends Immunol 2007; 28:184–192.
Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP . Control of the complement system. Adv Immunol 1996; 61:201–283.
Sim RB, Day AJ, Moffatt BE, Fontaine M . Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol 1993; 223:13–35.
Turnberg D, Botto M . The regulation of the complement system: insights from genetically-engineered mice. Mol Immunol 2003; 40:145–153.
Sharma AK, Pangburn MK . Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci USA 1996; 93:10996–11001.
Seya T, Hirano A, Matsumoto M, Nomura M, Ueda S . Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. Int J Biochem Cell Biol 1999; 31:1255–1260.
Wu J, Wu YQ, Ricklin D, et al. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 2009; 10:728–733.
Rooijakkers SH, Wu J, Ruyken M, et al. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol 2009; 10:721–727.
Blackmore TK, Hellwage J, Sadlon TA, et al. Identification of the second heparin-binding domain in human complement factor H. J Immunol 1998; 160:3342–3348.
Meri S, Morgan BP, Davies A, et al. Human protectin (CD59), an 18,000–20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 1990; 71:1–9.
Esser AF . The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994; 87:229–247.
Papadimitriou JC, Ramm LE, Drachenberg CB, Trump BF, Shin ML . Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J Immunol 1991; 147:212–217.
Cragg MS, Howatt WJ, Bloodworth L, et al. Complement mediated cell death is associated with DNA fragmentation. Cell Death Differ 2000; 7:48–58.
Sunyer JO, Boshra H, Li J . Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement. Vet Immunol Immunopathol 2005; 108:77–89.
Lienenklaus S, Ames RS, Tornetta MA, et al. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor. J Immunol 1998; 161:2089–2093.
Haas PJ, van Strijp J . Anaphylatoxins: their role in bacterial infection and inflammation. Immunol Res 2007; 37:161–175.
Wetsel RA . Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 1995; 7:48–53.
Hsu MH, Ember JA, Wang M, et al. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics 1997; 47:64–72.
Hollma TJ, Haviland DL, Kildsgaard J, Watts K, Wetsela RA . Cloning, expression, sequence determination, and chromosome localization of the mouse complement C3a anaphylatoxin receptor gene. Mol Immunol 1998; 35:137–148.
Bao L, Gerard NP, Eddy RL Jr, Shows TB, Gerard C . Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 1992; 13:437–440.
Haviland DL, McCoy RL, Whitehead WT, et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995; 154:1861–1869.
Monk PN, Scola AM, Madala P, Fairlie DP . Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007; 152:429–448.
Rabiet M, Huet E, Boulay F . The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007; 89:1089–1106.
Norgauer J, Dobos G, Kownatzki E, et al. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur J Biochem 1993; 217:289–294.
Zwirner J, Gotze O, Moser A, et al. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway. Eur J Immunol 1997; 27:2317–2322.
Vanek M, Hawkins LD, Gusovsky F . Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA. Mol Pharmacol 1994; 46:832–839.
Amatruda TT III, Gerard NP, Gerard C, Simon MI . Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem 1993; 268:10139–10144.
Buhl AM, Avdi N, Worthen GS, Johnson GL . Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci USA 1994; 91:9190–9194.
Gasque P, Singhrao SK, Neal JW, et al. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J Immunol 1998; 160:3543–3554.
Ischenko A, Sayah S, Patte C, et al. Expression of a functional anaphylatoxin C3a receptor by astrocytes. J Neurochem 1998; 71:2487–2496.
Oksjoki R, Laine P, Helske S, et al. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis 2007; 195:90–99.
Mizuno M, Blanchin S, Gasque P, Nishikawa K, Matsuo S . High levels of complement C3a receptor in the glomeruli in lupus nephritis. Am J Kidney Dis 2007; 49:598–606.
Lee H, Whitfeld PL, Mackay CR . Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 2008; 86:153–160.
Gutzmer R, Kother B, Zwirner J, et al. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 2006; 126:2422–2429.
Soruri A, Kim S, Kiafard Z, Zwirner J . Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody. Immunol Lett 2003; 88:47–52.
Zwirner J, Fayyazi A, Gotze O . Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 1999; 36:877–884.
Ross GD, Medof ME . Membrane complement receptors specific for bound fragments of C3. Adv Immunol 1985; 37:217–267.
van Lookeren Campagne M, Wiesmann C, Brown EJ . Macrophage complement receptors and pathogen clearance. Cell Microbiol 2007; 9:2095–2102.
Fearon DT . Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med 1980; 152:20–30.
Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A . Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 1997; 7:345–355.
Ghiran I, Barbashov SF, Klickstein LB, et al. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 2000; 192:1797–1808.
Krych-Goldberg M, Atkinson JP . Structure-function relationships of complement receptor type 1. Immunol Rev 2001; 180:112–122.
Bacle F, Haeffner-Cavaillon N, Laude M, Couturier C, Kazatchkine MD . Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes. J Immunol 1990; 144:147–152.
Molina H, Kinoshita T, Webster CB, Holers VM . Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J Immunol 1994; 153:789–795.
Ross GD . Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit Rev Immunol 2000; 20:197–222.
Helmy KY, Katschke KJ Jr, Gorgani NN, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006; 124:915–927.
Nussenzweig V, Bianco C, Dukor P, Eden A . Progress in Immunology. New York: Academic, 1971.
Pepys MB . Role of complement in induction of the allergic response. Nat New Biol 1972; 237:157–159.
Ochs HD, Wedgwood RJ, Heller SR, Beatty PG . Complement, membrane glycoproteins, and complement receptors: their role in regulation of the immune response. Clin Immunol Immunopathol 1986; 40:94–104.
O'Neil KM, Ochs HD, Heller SR, et al. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 1988; 140:1939–1945.
Papamichail M, Gutierrez C, Embling P, et al. Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol 1975; 4:343–347.
Kinoshita T, Thyphronitis G, Tsokos GC, et al. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int Immunol 1990; 2:651–659.
Fang Y, Xu C, Fu YX, Holers VM, Molina H . Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 1998; 160:5273–5279.
Carter RH and Fearon DT . CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256:105–107.
Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT . C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271:348–350.
Carsetti R, Kohler G, Lamers MC . Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995; 181:2129–2140.
Fleming SD, Shea-Donohue T, Guthridge JM, et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 2002; 169:2126–2133.
Reid RR, Woodcock S, Shimabukuro-Vornhagen A, et al. Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 2002; 169:5433–5440.
Ahearn JM, Fischer MB, Croix D, et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996; 4:251–262.
Barrington RA, Zhang M, Zhong X, et al. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol 2005; 175:2859–2867.
Fischer MB, Goerg S, Shen L, et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 1998; 280:582–585.
Cyster JG, Ansel KM, Reif K, et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev 2000; 176:181–193.
Barrington RA, Pozdnyakova O, Zafari MR, Benjamin CD, Carroll MC . B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med 2002; 196:1189–1199.
Fischer W, Hugli T . Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-α, IL-6, and the polyclonal immune response. J Immunol 1997; 159:4279–4286.
Morgan EL, Weigle WO, Hugli TE . Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J Exp Med 1982; 155:1412–1426.
Morgan EL, Thoman ML, Weigle WO, Hugli TE . Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol 1983; 130:1257–1261.
Kupp LI, Kosco MH, Schenkein HA, Tew JG . Chemotaxis of germinal center B cells in response to C5a. Eur J Immunol 1991; 21:2697–2701.
Ottonello L, Corcione A, Tortolina G, et al. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol 1999; 162:6510–6517.
Fearon DT, Carroll MC . Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000; 18:393–422.
Guinamard R, Okigaki M, Schlessinger J, Ravetch JV . Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000; 1:31–36.
Pozdnyakova O, Guttormsen HK, Lalani FN, Carroll MC, Kasper DL . Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol 2003; 170:84–90.
Molina H, Holers VM, Li B, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996; 93:3357–3361.
Da Costa XJ, Brockman MA, Alicot E, et al. Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci USA 1999; 96:12708–12712.
Mehlhop E, Diamond MS . Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 2006; 203:1371–1381.
Haas KM, Hasegawa M, Steeber DA, et al. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 2002; 17:713–723.
Janeway CA Jr . Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54 Pt 1:1–13.
Gustavsson S, Kinoshita T, Heyman B . Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol 1995; 154:6524–6528.
Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF . Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 2002; 8:373–378.
Kim AHJ, Dimitriou ID, Holland MCH, et al. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 2004; 173:2524–2529.
Peng Q, Li K, Anderson K, et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008; 111:2452–2461.
Fang C, Miwa T, Shen H, Song W . Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J Immunol 2007; 179:3178–3186.
Li K, Anderson KJ, Peng Q, et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008; 112:5084–5094.
Liu J, Miwa T, Hilliard B, et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 2005; 201:567–577.
Heeger PS, Lalli PN, Lin F, et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201:1523–1530.
Liu J, Lin F, Strainic MG, et al. IFN-γ and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 2008; 180:5882–5889.
Strainic MG, Liu J, Huang D, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008; 28:425–435.
Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS . Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008; 112:1759–1766.
Zhou W, Patel H, Li K, Peng Q, Villiers MB, Sacks SH . Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 2006; 107:2461–2469.
Martin U, Bock D, Arseniev L, et al. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med 1997; 186:199–207.
Werfel T, Kirchhoff K, Wittmann M, et al. Activated human T lymphocytes express a functional C3a receptor. J Immunol 2000; 165:6599–6605.
Zwirner J, Götze O, Begemann G, Kapp A, Kirchhoff K, Werfel T . Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology 1999; 97:166–172.
Nataf S, Davoust N, Ames RS, Barnum SR . Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 1999; 162:4018–4023.
Hopken UE, Lu B, Gerard NP, Gerard C . The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996; 383:86–89.
Zhang X, Kimura Y, Fang C, et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007; 110:228–236.
Hawlisch H, Kohl J . Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 2006; 43:13–21.
Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987–995.
Cattaneo R . Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 2004; 78:4385–4388.
Karp CL, Wysocka M, Wahl LM, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273:228–231.
Wagner C, Ochmann C, Schoels M, et al. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol Immunol 2006; 43:643–651.
Capasso M, Durrant LG, Stacey M, Gordon S, Ramage J, Spendlove I . Costimulation via CD55 on human CD4+ T cells mediated by CD97. J Immunol 2006; 177:1070–1077.
Mold C . Role of complement in host defense against bacterial infection. Microbes Infect 1999; 1:633–638.
Ross SC, Densen P . Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984; 63:243–273.
Orren A, Potter PC, Cooper RC, du Toit E . Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections: studies in 10 families and five isolated cases. Immunology 1987; 62:249–253.
Summerfield JA, Sumiya M, Levin M, Turner MW . Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314:1229–1232.
Silverman GJ, Goodyear CS, Siegel DL . On the mechanism of staphylococcal protein A immunomodulation. Transfusion 2005; 45:274–280.
Rooijakkers SH, Ruyken M, Roos A, et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 2005; 6:920–927.
Schmidtchen A, Holst E, Tapper H, Bjorck L . Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb Pathog 2003; 34:47–55.
Joiner KA, Warren KA, Brown EJ, Swanson J, Frank MM . Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol 1983; 131:1443–1451.
Joiner K, Brown E, Hammer C, Warren K, Frank M . Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. J Immunol 1983; 130:845–849.
Pausa M, Pellis V, Cinco M, et al. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol 2003; 170:3214–3222.
Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA . Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988; 85:1657–1661.
Ngampasutadol J, Ram S, Gulati S, et al. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol 2008; 180:3426–3435.
Schneider MC, Prosser BE, Caesar JJ, et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 2009; 458:890–893.
Lubinski J, Nagashunmugam T, Friedman HM . Viral interference with antibody and complement. Semin Cell Dev Biol 1998; 9:329–337.
de Haas CJ, Veldkamp KE, Peschel A, et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199:687–695.
Postma B, Poppelier MJ, van Galen JC, et al. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol 2004; 172:6994–7001.
Dorig RE, Marcil A, Chopra A, Richardson CD . The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75:295–305.
Lindahl G, Sjobring U, Johnsson E . Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol 2000; 12:44–51.
Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB . Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997; 25:639–647.
Evans DJ, Almond JW . Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends Microbiol 1998; 6:198–202.
Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD . Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 1997; 71:4736–4743.
Tanner J, Weis J, Fearon D, Whang Y, and Kieff E . Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 1987; 50:203–213.